NPJ precision oncology
| Autor principal: | |
|---|---|
| Autores Corporativos: | , |
| Formato: | Revista digital |
| Idioma: | Inglés |
| Publicado: |
[London] :
Springer Nature
[2017]-
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009434405406719 |
Tabla de Contenidos:
- Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
- Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
- Precision oncology- the future of personalized cancer medicine?
- Circulating tumor cells: quintessential precision oncology presenting challenges for biology
- Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
- EBV based cancer prevention and therapy in nasopharyngeal carcinoma
- Endothelial cell malignancies: new insights from the laboratory and clinic
- Revisiting the IGF-1R as a breast cancer target
- Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
- Targeting the duality of cancer
- Network-based machine learning and graph theory algorithms for precision oncology
- Immune cell profiling in cancer: molecular approaches to cell-specific identification
- Addressing the challenges of applying precision oncology
- Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
- Towards personalized tumor markers
- Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.
